Wing-Yen Wong

911 total citations
16 papers, 652 citations indexed

About

Wing-Yen Wong is a scholar working on Hematology, Genetics and Epidemiology. According to data from OpenAlex, Wing-Yen Wong has authored 16 papers receiving a total of 652 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Hematology, 3 papers in Genetics and 3 papers in Epidemiology. Recurrent topics in Wing-Yen Wong's work include Hemophilia Treatment and Research (10 papers), Blood Coagulation and Thrombosis Mechanisms (6 papers) and Platelet Disorders and Treatments (4 papers). Wing-Yen Wong is often cited by papers focused on Hemophilia Treatment and Research (10 papers), Blood Coagulation and Thrombosis Mechanisms (6 papers) and Platelet Disorders and Treatments (4 papers). Wing-Yen Wong collaborates with scholars based in United States, United Kingdom and Austria. Wing-Yen Wong's co-authors include Vasily Mamonov, Leonard A. Valentino, Andrzej Hellmann, P Schroth, Doris Quon, Lisa Patrone, Alicja Chybicka, Bruce M. Ewenstein, Oleksandra Stasyshyn and Darleen Powars and has published in prestigious journals such as Blood, The Journal of Pediatrics and Journal of Thrombosis and Haemostasis.

In The Last Decade

Wing-Yen Wong

16 papers receiving 633 citations

Peers

Countries citing papers authored by Wing-Yen Wong

Since Specialization

Citations

This map shows the geographic impact of Wing-Yen Wong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wing-Yen Wong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wing-Yen Wong more than expected).

Fields of papers citing papers by Wing-Yen Wong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wing-Yen Wong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wing-Yen Wong. The network helps show where Wing-Yen Wong may publish in the future.

Co-authorship network of co-authors of Wing-Yen Wong

This figure shows the co-authorship network connecting the top 25 collaborators of Wing-Yen Wong. A scholar is included among the top collaborators of Wing-Yen Wong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wing-Yen Wong. Wing-Yen Wong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	A FIRST-IN-HUMAN FOUR-YEAR FOLLOW-UP STUDY OF DURABLE THERAPEUTIC EFFICACY AND SAFETY OF AAV GENE THERAPY WITH VALOCTOCOGENE ROXAPARVOVEC FOR SEVERE HEMOPHILIA A 2020 ·Hematology Transfusion and Cell Therapy ·Margareth C. Ozelo, John Pasi, Savita Rangarajan, Nina Mitchell, Will Lester, Emily Symington, (unknown), Michael Laffan, Chris B. Russell, (unknown), (unknown), Glenn F. Pierce, Wing-Yen Wong	3
2	Integrated analysis of safety data from 12 clinical interventional studies of plasma‐ and albumin‐free recombinant factor VIII (rAHF‐PFM) in haemophilia A 2015 ·Haemophilia ·(unknown), (unknown), (unknown), Wing-Yen Wong, (unknown)	6
3	ADVATE prophylaxis: post hoc analysis of joint bleeding episodes 2014 ·Haemophilia ·Leonard A. Valentino, Carolina Reyes, Bruce M. Ewenstein, Norma Guzmán‐Becerra, Wing-Yen Wong, (unknown), (unknown)	5
4	Pharmacokinetics and safety of a novel recombinant human von Willebrand factor manufactured with a plasma-free method: a prospective clinical trial 2013 ·Blood ·Pier Mannuccio Mannucci, Christine L. Kempton, Carolyn M. Millar, Edward H. Romond, Amy D. Shapiro, Ingvild Birschmann, Margaret V. Ragni, Joan Cox Gill, T. T. Yee, Robert Klamroth, Wing-Yen Wong, (unknown), Werner Engl, Peter L. Turecek, (unknown), Bruce M. Ewenstein	87
5	Pharmacokinetics, efficacy and safety of BAX326, a novel recombinant factor IX: a prospective, controlled, multicentre phase I/III study in previously treated patients with severe (FIX level <1%) or moderately severe (FIX level ≤2%) haemophilia B 2013 ·Haemophilia ·Jerzy Windyga, Toshko Lissitchkov, Oleksandra Stasyshyn, Vasily Mamonov, L. Rusen, (unknown), Myungshin Oh, Martin D. Chapman, S. Fritsch, Borislava G. Pavlova, Wing-Yen Wong, Brigitt E. Abbuehl	41
6	Development of novel treatment options for patients with haemophilia 2013 ·Hämostaseologie ·Hartmut J. Ehrlich, Wing-Yen Wong, Bruce M. Ewenstein, Michael Dockal, P. L. Turecek, A. Gringeri, (unknown), (unknown), Friedrich Scheiflinger, Armin J. Reininger	4
7	Randomized comparison of prophylaxis and on‐demand regimens with FEIBA NF in the treatment of haemophilia A and B with inhibitors 2013 ·Haemophilia ·Sandra Vallin Antunes, Srilatha Tangada, Oleksandra Stasyshyn, Vasily Mamonov, J. Phillips, Norma Guzmán‐Becerra, (unknown), Bruce M. Ewenstein, Wing-Yen Wong	94
8	SURgical interventions with FEIBA (SURF): international registry of surgery in haemophilia patients with inhibitory antibodies 2013 ·Haemophilia ·Claude Négrier, Anne Lienhart, Robert P. Numerof, Darby Stephens, Wing-Yen Wong, Fariba Baghaei, T. T. Yee	27
9	A randomized comparison of two prophylaxis regimens and a paired comparison of on‐demand and prophylaxis treatments in hemophilia A management 2011 ·Journal of Thrombosis and Haemostasis ·Leonard A. Valentino, Vasily Mamonov, Andrzej Hellmann, Doris Quon, Alicja Chybicka, P Schroth, Lisa Patrone, Wing-Yen Wong	203
10	Severe Congenital Protein C Deficiency: Description of a New Mutation and Prophylactic Protein C Therapy and In Vivo Pharmacokinetics 2008 ·Journal of Pediatric Hematology/Oncology ·(unknown), Sinisa Dovat, Zafer Gürel, (unknown), Wing-Yen Wong	14
11	Recombinant factor VIIa prophylaxis in a patient with severe congenital factor VII deficiency 2004 ·Haemophilia ·(unknown), (unknown), (unknown), Wing-Yen Wong	24
12	Invasive pneumococcal infections in children with sickle cell disease in the era of penicillin prophylaxis, antibiotic resistance, and 23-valent pneumococcal polysaccharide vaccination 2003 ·The Journal of Pediatrics ·Thomas V. Adamkiewicz, Sharada A. Sarnaik, George R. Buchanan, Rathi V. Iyer, Scott T. Miller, Charles H. Pegelow, Zora R. Rogers, Elliott Vichinsky, John A. Elliott, Richard R. Facklam, Katherine L. O’Brien, Benjamin Schwartz, Chris Van Beneden, Michael J. Cannon, James R. Eckman, Harry Keyserling, Kevin M. Sullivan, Wing-Yen Wong, Winfred C. Wang	97
13	Incomplete Cerebral Infarctions Are not Silent 2001 ·The American journal of pediatric hematology/oncology ·Darleen Powars, Wing-Yen Wong, Linda Vachon	8
14	Antibiotic-Resistant Pneumococcal Infection in Children with Sickle Cell Disease in the United States 1996 ·Journal of Pediatric Hematology/Oncology ·Winfred C. Wang, Wing-Yen Wong, Zora R. Rogers, Judith A. Wilimas, George R. Buchanan, Darleen Powars	16
15	RENAL FAILURE IN SICKLE CELL ANEMIA 1996 ·Hematology/Oncology Clinics of North America ·Wing-Yen Wong, (unknown), Darleen Powars	22
16	'Yewdow'-induced anemia. 1989 ·PubMed ·Wing-Yen Wong, (unknown), (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact